JP2022521973A5 - - Google Patents

Info

Publication number
JP2022521973A5
JP2022521973A5 JP2021549772A JP2021549772A JP2022521973A5 JP 2022521973 A5 JP2022521973 A5 JP 2022521973A5 JP 2021549772 A JP2021549772 A JP 2021549772A JP 2021549772 A JP2021549772 A JP 2021549772A JP 2022521973 A5 JP2022521973 A5 JP 2022521973A5
Authority
JP
Japan
Prior art keywords
subject
alcam
soluble
composition according
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021549772A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521973A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019990 external-priority patent/WO2020176682A1/en
Publication of JP2022521973A publication Critical patent/JP2022521973A/ja
Publication of JP2022521973A5 publication Critical patent/JP2022521973A5/ja
Ceased legal-status Critical Current

Links

JP2021549772A 2019-02-26 2020-02-26 抗cd6抗体組成物およびループスを処置するための方法 Ceased JP2022521973A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962810628P 2019-02-26 2019-02-26
US62/810,628 2019-02-26
US201962933294P 2019-11-08 2019-11-08
US62/933,294 2019-11-08
PCT/US2020/019990 WO2020176682A1 (en) 2019-02-26 2020-02-26 Anti-cd6 antibody compositions and methods for treating lupus

Publications (2)

Publication Number Publication Date
JP2022521973A JP2022521973A (ja) 2022-04-13
JP2022521973A5 true JP2022521973A5 (cg-RX-API-DMAC7.html) 2023-03-02

Family

ID=70009403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021549772A Ceased JP2022521973A (ja) 2019-02-26 2020-02-26 抗cd6抗体組成物およびループスを処置するための方法

Country Status (12)

Country Link
US (1) US20220143140A1 (cg-RX-API-DMAC7.html)
EP (1) EP3930751A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022521973A (cg-RX-API-DMAC7.html)
CN (1) CN113490511B (cg-RX-API-DMAC7.html)
AU (1) AU2020229830A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021016967A2 (cg-RX-API-DMAC7.html)
CA (1) CA3131299A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021010283A (cg-RX-API-DMAC7.html)
PH (1) PH12021551994A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202109118XA (cg-RX-API-DMAC7.html)
WO (1) WO2020176682A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202107077B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2993186T (pt) 2008-03-14 2019-11-29 Biocon Ltd Anticorpo monoclonal e um método do mesmo
IL303290A (en) * 2020-12-04 2023-07-01 Equillium Inc Methods of selectively targeting cd6 high cells and decreasing activity of t eff cells
EP4533094A4 (en) * 2022-05-25 2026-05-06 Univ Houston System METHODS AND SYSTEMS FOR RISK STRATIFICATION AND BLADDER CANCER MANAGEMENT
TWI869873B (zh) * 2023-06-05 2025-01-11 中國醫藥大學 一種檢測一個體罹患單純復發性風濕病的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998172A (en) * 1993-11-02 1999-12-07 Duke University Anti-CD6 ligand antibodies
CU22615A1 (es) 1994-06-30 2000-02-10 Centro Inmunologia Molecular Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
CU22584A1 (es) 1995-11-17 1999-11-03 Centro Inmunologia Molecular Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis
AU747898B2 (en) * 1997-03-03 2002-05-30 Bristol-Myers Squibb Company Monoclonal antibodies to human CD6
MY154819A (en) 2006-12-26 2015-07-31 Centro Inmunologia Molecular Pharmaceutical compositions with capacity to induce adoptosis in tumor cells for the diagnosis and treatment of the b-cell chroniclymphocytic leukemia
PT2993186T (pt) * 2008-03-14 2019-11-29 Biocon Ltd Anticorpo monoclonal e um método do mesmo
WO2012133047A1 (ja) * 2011-03-25 2012-10-04 コニカミノルタエムジー株式会社 免疫組織染色法、およびこれを用いた抗体医薬の有効性を判定する方法
EP2726879B1 (en) * 2011-07-01 2022-10-19 Beckman Coulter, Inc. Requlatory t cells and methods of identifying and isolating them using cd6 -expression or the combination of cd4, cd25 and cd127
CA2866612C (en) * 2012-03-08 2018-01-16 Halozyme, Inc. Conditionally active ph-dependent cetuximab variant anti-epidermal growth factor receptor antibodies and method of use thereof
US10620201B2 (en) * 2014-01-20 2020-04-14 Pad 4 Di Maria Adele Silvia Denegri S.A.S. In vitro method for predicting, diagnosing and monitoring in therapeutic follow up lupus nephritis
SG11201808625QA (en) * 2016-04-04 2018-10-30 Chemocentryx Inc SOLUBLE C5aR ANTAGONISTS
WO2017214452A1 (en) * 2016-06-08 2017-12-14 Xencor, Inc. Treatment of igg4-related diseases with anti-cd19 antibodies crossbinding to cd32b
KR102514528B1 (ko) * 2016-10-21 2023-03-27 바이오콘 리미티드 루푸스 치료를 위한 단일클론항체 및 이의 치료방법

Similar Documents

Publication Publication Date Title
US10822403B2 (en) Composition and method for the diagnosis and treatment of iron-related disorders
RU2636345C2 (ru) Новое антитело к cxcr4 и его применение для выявления и диагностики рака
JP6138780B2 (ja) 癌の検出および診断のための抗体i−3859の使用
CA3091801A1 (en) B7-h4 antibodies and methods of use thereof
HUE030578T2 (en) Antibody recognising human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation
EP3589652B1 (en) Recombinant antibodies to programmed death 1 (pd-1) and uses therefor
CN113490511B (zh) 用于治疗狼疮的抗cd6抗体组合物和方法
CN114650866B (zh) 新的用于诊断的分子
US20230287512A1 (en) Marker for response to pd-1/pd-l1 immunotherapy
KR20190130506A (ko) 골수유래억제세포 관련 질환의 예방 및 치료 용도
JP2025533015A (ja) 薬物抵抗性肝細胞癌の処置
EP4471057A1 (en) Anti-human cxcl1 antibody
US11009507B2 (en) Methods and diagnostics for cancer detection and treatment monitoring
KR20180118151A (ko) 다발성 골수종에서 m-단백질 반응의 임상 평가
JP7300687B2 (ja) 肝細胞癌診断用バイオマーカーセレブロンと、これに特異的な新規なモノクローナル抗体
US20230093265A1 (en) New method and compound for prostate cancer diagnosis
TWI869740B (zh) 一種體外檢測sTNFR2蛋白濃度的方法及其檢測試劑和檢測試劑盒
CN110596369A (zh) 一种用于检测人tim-3表达水平的试剂盒
CN110891604B (zh) 靶向人TAXILINα的单克隆抗体及其使用方法
US10823735B2 (en) Monoclonal antibody for predicting tamoxifen response in breast cancer patients
JP4851620B2 (ja) Nk4に対するモノクローナル抗体
CN118684779A (zh) 一种抗Trop2单克隆抗体药物或其衍生物的特异性结合剂及其应用
CN116710575A (zh) 对pd-1/pd-l1免疫疗法有反应的标志物
NZ749138A (en) Monoclonal antibodies, compositions and methods for detecting mucin -like protein (mlp) as a biomarker for ovarian and pancreatic cancer
NZ749138B2 (en) Monoclonal antibodies, compositions and methods for detecting mucin -like protein (mlp) as a biomarker for ovarian and pancreatic cancer